Search

everythinglearnresearchcommunity

for

Search:↓

Women have smaller foreheads and different hairline shapes than men.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Transgender and gender diverse youth often have skin issues like acne and scarring, but few get referred to dermatologists.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Gender-affirming hormone therapy may increase heart disease risk in transgender individuals.

Denying transgender minors gender-affirming care, while allowing it for cisgender minors, is sex discrimination.

The patient was satisfied with hormone therapy, and her epilepsy remained stable.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Social rejection can harm long-term mental health in transgender individuals.

Bicalutamide may help treat female pattern hair loss.

Alopecia areata causes significant emotional and social challenges, especially with more hair loss.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

Accurate gender and sex assessment in dermatology is essential for respectful and precise patient care.

Collecting sexual orientation and gender identity data in dermatology can lead to better, more sensitive care for sexual and gender minority patients.

Female authorship in dermatology publications increased during the COVID-19 pandemic, but women are still underrepresented in senior roles.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Understanding gender differences in COVID-19 is crucial for effective health strategies.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Young transgender, gender diverse, and nonbinary people on spironolactone have a low risk of high potassium, so frequent monitoring may not be needed.

Adults with gender dysphoria on hormone treatment often have skin problems like acne, which are common but not always recognized.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

Estrogen alone can lower testosterone in some transfeminine people.

Minoxidil can help transgender males grow facial hair before starting testosterone therapy.

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.

Alopecia in transgender individuals on hormone therapy can worsen emotional distress and affect self-esteem.

The document concludes that careful planning and execution of facial gender affirmation surgery after at least 12 months of hormonal therapy can improve the quality of life for transgender individuals.

Targeted interventions based on gender, education, and age can improve COVID-19 healthcare responses.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.